Contemporary management of atrial fibrillation: a brief review

Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 Dries, 1998, J Am Coll Cardiol, 32, 695, 10.1016/S0735-1097(98)00297-6 El-Chami, 2010, New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft, J Am Coll Cardiol, 55, 1370, 10.1016/j.jacc.2009.10.058 Pedersen, 2006, Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure, Eur Heart J, 27, 2866, 10.1093/eurheartj/ehl359 Falk, 2001, Medical progress: Atrial fibrillation, N Engl J Med, 344, 1067, 10.1056/NEJM200104053441407 The CONSENSUS Trial Study Group, 1987, Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group, N Engl J Med, 316, 1429 Moe, 1964, A computer model of atrial fibrillation, Am Heart J, 67, 200, 10.1016/0002-8703(64)90371-0 Allessie, 1985, Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation, 265 Konings, 1994, High-density mapping of electrically induced atrial fibrillation in humans, Circulation, 89, 1665, 10.1161/01.CIR.89.4.1665 Haissaguerre, 1998, Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N Engl J Med, 339, 659, 10.1056/NEJM199809033391003 Chen, 1999, Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation, Circulation, 100, 1879, 10.1161/01.CIR.100.18.1879 Gosselink, 1992, Low dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter, JAMA, 267, 3289, 10.1001/jama.1992.03480240051033 Chun, 1995, Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter, Am J Cardiol, 76, 47, 10.1016/S0002-9149(99)80799-1 Olshansky, 2004, AFFIRM Investigators The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study: Approaches to control rate in atrial fibrillation, J Am Coll Cardiol, 43, 1201, 10.1016/j.jacc.2003.11.032 Oake, 2007, Frequency of adverse events in patients with poor anticoagulation: A meta-analysis, CMAJ, 176, 1589, 10.1503/cmaj.061523 Wang, 2008, Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in Australia: a restrospective stuy, Curr Ther Res, 69, 514, 10.1016/j.curtheres.2008.12.001 Sherman, 2005, National Heart, Lung, and Blood Institute AFFIRM Investigators. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study, Arch Intern Med, 165, 1185, 10.1001/archinte.165.10.1185 Stroke Prevention in Atrial Fibrillation Investigators, 1991, Stroke Prevention in Atrial Fibrillation Study: Final results, Circulation, 84, 527, 10.1161/01.CIR.84.2.527 Hart, 2000, Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators, J Am Coll Cardiol, 35, 183, 10.1016/S0735-1097(99)00489-1 Monte, 2006, Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation, Eur Heart J, 27, 2217, 10.1093/eurheartj/ehl208 Evans, 2001, Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?, Stroke, 32, 2828, 10.1161/hs1201.099520 Cox, 1991, The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure, J Thorac Cardiovasc Surg, 101, 569, 10.1016/S0022-5223(19)36684-X Cox, 1993, Five-year experience with the maze procedure for atrial fibrillation, Ann Thorac Surg, 56, 814, 10.1016/0003-4975(93)90338-I Pappone, 2000, Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation, Circulation, 102, 2619, 10.1161/01.CIR.102.21.2619 Jais, 2004, Technique and results of linear ablation at the mitral isthmus, Circulation, 110, 2996, 10.1161/01.CIR.0000146917.75041.58 Arentz, 2003, Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation, Circulation, 108, 2484, 10.1161/01.CIR.0000097118.75179.83 Oral, 2006, A tailored approach to catheter ablation of paroxysmal atrial fibrillation, Circulation, 113, 1824, 10.1161/CIRCULATIONAHA.105.601898 Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983 van Walraven, 2003, A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin, Arch Intern Med, 163, 936, 10.1001/archinte.163.8.936 Hart, 1999, Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis, Ann Intern Med, 131, 492, 10.7326/0003-4819-131-7-199910050-00003 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Fuster, 2006, Circulation, 114, e257, 10.1161/CIRCULATIONAHA.106.177292 Connolly, 2009, RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Medi, 2007, Atrial fibrillation, Med J Aust, 186, 197, 10.5694/j.1326-5377.2007.tb00862.x ACTIVE Investigators, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, 360, 2066, 10.1056/NEJMoa0901301 ACTIVE Writing Group of the ACTIVE Investigators, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet, 367, 1903, 10.1016/S0140-6736(06)68845-4 Lip, 2006, Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline, Chest, 130, 1823, 10.1378/chest.130.6.1823 Nieuwlaat, 2005, European Heart Survey Investigators. Atrial fibrillation management: A prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation, Eur Heart J, 26, 2422, 10.1093/eurheartj/ehi505 Wyse, 2002, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328 Tamariz, 2004, Pharmacological rate control of atrial fibrillation, Cardiol Clin, 22, 35, 10.1016/S0733-8651(03)00111-5 Hohnloser, 2009, ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation, N Engl J Med, 360, 668, 10.1056/NEJMoa0803778 Iesaka, 2007, Catheter ablation therapy for atrial fibrillation current advancements in strategies, Circ J, A82, 10.1253/circj.71.A82 Cappato, 2005, Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation, 111, 1100, 10.1161/01.CIR.0000157153.30978.67 Jais, 2008, Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation, 118, 2498, 10.1161/CIRCULATIONAHA.108.772582 Crandall, 2009, Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies, Mayo Clin Proc, 84, 643, 10.1016/S0025-6196(11)60754-4 Ostermayer, 2005, Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials, J Am Coll Cardiol, 46, 9, 10.1016/j.jacc.2005.03.042 Holmes, 2009, PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial, Lancet, 374, 534, 10.1016/S0140-6736(09)61343-X